The global immunoprotein diagnostic testing market is projected in a report by Transparency Market Research (TMR) to see a rise in research and development efforts taken by companies to gain a strong foothold. Other business strategies that could be adopted in the market are regional expansion, tactical partnership, merger and acquisition, and new product development.
Beckman Coulter, Inc. and Ortho Clinical Diagnostics joined hands in June 2016 for the sale of VITROS 3600 Immunodiagnostic System. In May 2016, DiaSorin entered into a purchase agreement with Quest Diagnostics to buy Focus Diagnostics’ molecular diagnostic and immunodiagnostic products business. The TMR report identifies Abcam PLC, Binding Site Group Ltd., and Thermo Fisher Scientific, Inc. as other important players of the market.
According to the report, the global immunoprotein diagnostic testing market could earn US$15.3 bn by the end of 2019. In terms of application, oncology testing is expected to account for a larger share of the market, bagging a US$4.9 bn by the same year. By region, North America could take hold of a king’s share of the market all through the course of the forecast period.
Growing Demand for Preventive Healthcare in Emerging Economies Augurs Well
Developing countries with increasing demand for preventive, accurate, and quick healthcare are anticipated to set the tone for valuable growth in the world immunoprotein diagnostic testing market. Growth of the market could also be supported by expanded global distributor network, improved use of immunochromatography, commoditization of products, and technological advancement.
Owing to its advantages such as ease of use, safety, sensitivity, wide-scale application, and feasibility, chemiluminescent assay is said to have achieved massive demand in the recent past. Free light chain diagnostic tests are expected to show a quick rise in growth considering their initial stages of development. On the other hand, C-reactive protein diagnostic tests could be largely used because of their accurate and effective diagnosis of cardiovascular diseases, strokes, inflammation-related disorders, and injuries.
High Cost of Diagnosis and Unaffordability of Low-income Patients Restrict Growth
The international immunoprotein diagnostic testing market is foreseen to carry an impressive growth potential for the next few years. However, there could be some factors paralyzing the rise of market growth. For instance, expensive cost of diagnosis and unaffordability of patients in less developed nations are foretold to hamper the demand in the market. Nonetheless, urgent need for fast diagnosis due to rising mortality rate on account of high prevalence of type 2 diabetes, rheumatoid arthritis, cancer, and other chronic diseases is prognosticated to create lucrative prospects in the market. Furthermore, companies are recommended to upgrade to latest technology, tap into the future of oncology testing, and explore opportunities in the allergy testing market to increase their share.
The information presented in this review is based on a TMR report, titled “Immunoprotein Diagnostic Testing Market (Assay Technology - Radioimmunoassay, Enzyme-based Immunoassay, Chemiluminescent Assay, Immunofluorescence Assay, Immunoturbidity Assay, and Immunoprotein Electrophoresis; Immunoprotein Type - Complement System Proteins Diagnostic Tests, Free Light Chain Diagnostic Tests, Haptoglobin Diagnostic Tests, Immunoglobulin Diagnostic Tests, Prealbumin Diagnostic Tests, and C-reactive Protein (CRP) Diagnostic Tests; Application - Infectious Disease Testing, Oncology Testing, Endocrine Testing, Toxicology Testing, Allergy Testing, and Autoimmune Disease Testing) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019.”
The global immunoprotein diagnostic testing market has been segmented as presented below:
Global Immunoprotein Diagnostic Testing Market: Assay Technology
- Enzyme-based Immunoassay
- Chemiluminescent Assay
- Immunofluorescence Assay
- Immunoturbidity Assay
- Immunoprotein Electrophoresis
Global Immunoprotein Diagnostic Testing Market: Immunoprotein Type
- Complement System Proteins Diagnostic Tests
- Free Light Chain Diagnostic Tests
- Haptoglobin Diagnostic Tests
- Immunoglobulin Diagnostic Tests
- Prealbumin Diagnostic Tests
- C-reactive Protein (CRP) Diagnostic Tests
Global Immunoprotein Diagnostic Testing Market: Application
- Infectious Disease Testing
- Oncology Testing
- Endocrine Testing
- Toxicology Testing
- Allergy Testing
- Autoimmune Disease Testing
Global Immunoprotein Diagnostic Testing Market: Region
- North America
- Asia Pacific
- Rest of World
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
7 of 10 large enterprizes view our ToC to take the right decision.View Report ToC